Global Complete Blood Count (CBC) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Complete Blood Count (CBC) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

A complete blood count (CBC), also known as a complete blood count (FBC), is a set of medical laboratory tests that provide information about the cells in a person's blood. CBC is usually performed as part of a medical evaluation and can be used to monitor health or diagnose disease. Interpret the results by comparing the results with the reference range, which varies by gender and age. Conditions like conditional anemia and thrombocytopenia are defined by abnormal complete blood count results. The red blood cell index can provide information about the causes of a person's anemia, such as iron deficiency and vitamin B12 deficiency, and the results of white blood cell classification can help diagnose viral, bacterial, and parasitic infections and blood diseases such as leukemia.

Market Overview:

The latest research study on the global Complete Blood Count (CBC) market finds that the global Complete Blood Count (CBC) market reached a value of USD 2152.6 million in 2022. It’s expected that the market will achieve USD 3333.26 million by 2028, exhibiting a CAGR of 7.56% during the forecast period.

Short-term Complete Blood Count (CBC) diagnostic examination service demand drops

During COVID-19, people stay in isolation at home, and many physical examinations and basic treatments have to be postponed. At this stage, people are focusing on epidemic prevention, because hospitals are in a special position for COVID-19 epidemic prevention, and people's access to hospitals is controlled, and the overall demand for routine inspections has weakened.

Long-term positive impact

First of all, basic inspections are just needed. With the recovery of the epidemic, the entire diagnostic service market has recovered relatively quickly. In the post-epidemic period, people’s emphasis on health has increased, the demand for routine inspections has increased, and the demand for Complete Blood Count (CBC) has increased.

Political Factors

National Medical Insurance

In Western developed countries such as Europe and the United States, medical care is the country's basic guarantee. Blood testing is also in the scope of medical care. The degree of marketization is low, and the market is basically in a state of non-competition. Laggard developing countries do not have the financial and material resources to guarantee basic medical care, and medical expenses need to be paid by patients. There is fierce competition in medical care, and competition in blood testing is also fierce. Price competition is the main form of competition. Different countries have different medical security requirements for blood testing, and populations have different needs for routine testing. For the tests that are included in the basic guarantee, people are willing to conduct tests on a regular basis. Conversely, in countries that are not covered by the guarantee, people's demand for complete blood counts has weakened.

Universal health coverage (UHC)

Achieving universal health coverage is one of the goals set by countries around the world when they adopted the Sustainable Development Goals in 2015. Countries reaffirmed this commitment at the 2019 UN General Assembly High-Level Meeting on Universal Health Coverage. Countries that have made progress in universal health coverage will achieve progress in other health-related goals and move toward other goals. Health allows children to learn, adults earn money, help people get rid of poverty, and provides a foundation for long-term economic development. A consensus on universal health coverage and policy advancement is conducive to the increase in people’s demand for complete blood count services.

Economic Factors

Increase in personal disposable income

With the increase in personal disposable income, people pay more and more attention to health and pay more attention to regular check-ups. The complete blood count item is a relatively routine item in regular inspections, and the need is increasing.

Macroeconomics is friendly to the medical market

The overall macroeconomic is developing steadily. Even if the economy is severely hit by COVID-19, the overall rigidity and resilience of the medical market are strong, and the overall capital market is optimistic about the medical market. Related companies have a greater chance of obtaining investment and financing.

Region Overview:

In global comparison, a significant portion of the revenue was generated in North America (37.06% in 2021).

Company Overview:

Sysmex is one of the major players operating in the Complete Blood Count (CBC) market, holding a share of 35.41% in 2022.

Sysmex

Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis.

Abbott

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices.

Segmentation Overview:

As for product types, the RBC Count segment held the largest market share in 2021.

Application Overview:

The market's largest segment by application is the segment Hospital, with a market share of 67.13% in 2021.

Key Companies in the global Complete Blood Count (CBC) market covered in Chapter 3:

Nihon Kohden
Horiba
Sysmex
Danaher corporation
Abbott
Thermo Fisher
Siemens Healthcare
Mindray
BD

In Chapter 4 and Chapter 14.2, on the basis of types, the Complete Blood Count (CBC) market from 2018 to 2029 is primarily split into:

WBC Count
RBC Count
Platelet Count

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Complete Blood Count (CBC) market from 2018 to 2029 covers:

Hospital
Reference Laboratories

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)